Showing 32,081 - 32,100 results of 32,186 for search '(( significantly better decrease ) OR ( significantly ((better decrease) OR (between decreased)) ))', query time: 0.69s Refine Results
  1. 32081

    DataSheet1_Arctic stratosphere changes in the 21st century in the Earth system model SOCOLv4.pdf by Pavel Vargin (16809465)

    Published 2023
    “…The statistically significant long-term stratospheric sulfuric acid aerosol trend in March is expected only in the SSP5.8-5 scenario, most probably due to cooler stratosphere and stronger Brewer–Dobson circulation intensification. …”
  2. 32082

    Image_1_Effect of High-Intensity Interval Training on Body Composition, Cardiorespiratory Fitness, Blood Pressure, and Substrate Utilization During Exercise Among Prehypertensive a... by Pedro Delgado-Floody (9534113)

    Published 2020
    “…We also aimed to test the potential association between changes in cardiorespiratory fitness, substrate utilization during exercise and BP. …”
  3. 32083

    DataSheet1_Biomarkers of response to ocrelizumab in relapsing–remitting multiple sclerosis.pdf by Fernando Rodríguez-Jorge (17279800)

    Published 2024
    “…Decrease in sGFAP values occurred later in both groups, with significant reductions observed at 12 months for INFL and 6 and 12 months for NEDA-3. …”
  4. 32084

    CDK2/Speedy A localization in <i>Cdk2</i><sup><i>−/−</i></sup> and <i>Speedy A</i><sup><i>−/−</i></sup> spermatocytes. by Nathan Palmer (264897)

    Published 2020
    “…Error bars are indicative of the mean and SD. Statistical significance between genotypes was determined by unpaired <i>t</i> test. …”
  5. 32085

    DataSheet1_Biomarkers of response to ocrelizumab in relapsing–remitting multiple sclerosis.pdf by Fernando Rodríguez-Jorge (17279800)

    Published 2024
    “…Decrease in sGFAP values occurred later in both groups, with significant reductions observed at 12 months for INFL and 6 and 12 months for NEDA-3. …”
  6. 32086

    Table_1_Canagliflozin alters the gut, oral, and ocular surface microbiota of patients with type 2 diabetes mellitus.docx by Limin Wang (87511)

    Published 2023
    “…</p>Clinical parameters<p>A significant decrease in fasting plasma glucose (8.22 ± 2.19 vs 6.87 ± 1.09 mmol/L), glycated serum protein [291.00 (264.00, 353.00) vs 275.00 (251.00, 342.50) μmol/L], hemoglobin A1c (7.39 ± 1.18 vs 7.12 ± 1.33%), body mass index (25.32 ± 2.99 vs 24.83 ± 2.95 kg/m<sup>2</sup>), systolic blood pressure (129.05 ± 17.51 vs 123.43 ± 14.82 mmHg), and urinary creatinine [158.40 (74.75, 219.15) vs 79.70 (56.25, 138.10) μmmol/kg] levels was noted after 30-day Cana monotherapy (P < 0.05).…”
  7. 32087

    Absence of AMX-1 induces DNA damage checkpoint activation and AMX-1 is required for sensitivity upon interstrand crosslink damage. by Xiaojuan Zhang (235854)

    Published 2021
    “…Asterisks indicate statistical significance between wild type and <i>amx-1</i> calculated by the two-tailed Mann-Whitney test, 95% C.I. …”
  8. 32088

    A small proportion of Talin molecules at muscle attachment sites in vivo are mechanically engaged. by Sandra B. Lemke (6519788)

    Published 2019
    “…Note that both sensors indicate forces across Talin at 20 h and 24 h APF (significance indicated in black). Direct comparisons between TS and stTS or the controls are indicated in orange. …”
  9. 32089

    Supplementary Material for: Effect of Transcranial Alternating Current Stimulation for the Treatment of Chronic Insomnia: A Randomized, Double-Blind, Parallel-Group, Placebo-Contro... by Wang H.-X. (8135109)

    Published 2019
    “…During the trial, compared with the sham group, the active group showed a statistically significant decrease in PSQI total score, a shortened SOL, an increased TST, improved sleep efficiency, and improved sleep quality (<i>p</i> < 0.05 or <i>p</i> < 0.001). …”
  10. 32090

    Source apportionment of PM<sub>2.5</sub> at IMPROVE monitoring sites within and outside of marine vessel fuel sulfur emissions control areas by Robert A. Kotchenruther (11235072)

    Published 2021
    “…These sites saw a statistically significant 14.0% increase, a 21.0% decrease, or no statistically significant change, respectively, when comparing time periods pre and post ECA enforcement.…”
  11. 32091

    ACh signals measured in rat mPFC by Howe et al. during the SAT. by Sahiti Chebolu (14035041)

    Published 2022
    “…<p>(A) Signal trials. Left: a significant increase in ACh on signal trials in which an animal correctly reported a signal (i.e., hit trial), but only when a non-signal was reported on the previous trial (‘incongruent hit’) and not if the previous trial was also a hit trial (‘consecutive hit’). …”
  12. 32092

    DataSheet_1_Canagliflozin alters the gut, oral, and ocular surface microbiota of patients with type 2 diabetes mellitus.xls by Limin Wang (87511)

    Published 2023
    “…</p>Clinical parameters<p>A significant decrease in fasting plasma glucose (8.22 ± 2.19 vs 6.87 ± 1.09 mmol/L), glycated serum protein [291.00 (264.00, 353.00) vs 275.00 (251.00, 342.50) μmol/L], hemoglobin A1c (7.39 ± 1.18 vs 7.12 ± 1.33%), body mass index (25.32 ± 2.99 vs 24.83 ± 2.95 kg/m<sup>2</sup>), systolic blood pressure (129.05 ± 17.51 vs 123.43 ± 14.82 mmHg), and urinary creatinine [158.40 (74.75, 219.15) vs 79.70 (56.25, 138.10) μmmol/kg] levels was noted after 30-day Cana monotherapy (P < 0.05).…”
  13. 32093

    Comparison of RPA2 dynamics in WT, <i>Cdk2</i><sup><i>T160A</i></sup>, <i>and Cdk2</i><sup><i>−/−</i></sup> spermatocytes. by Nathan Palmer (264897)

    Published 2020
    “…All data were assumed to be non-normally distributed. Statistical significance between genotypes was determined by unpaired <i>t</i> test. …”
  14. 32094

    DataSheet_3_Canagliflozin alters the gut, oral, and ocular surface microbiota of patients with type 2 diabetes mellitus.xls by Limin Wang (87511)

    Published 2023
    “…</p>Clinical parameters<p>A significant decrease in fasting plasma glucose (8.22 ± 2.19 vs 6.87 ± 1.09 mmol/L), glycated serum protein [291.00 (264.00, 353.00) vs 275.00 (251.00, 342.50) μmol/L], hemoglobin A1c (7.39 ± 1.18 vs 7.12 ± 1.33%), body mass index (25.32 ± 2.99 vs 24.83 ± 2.95 kg/m<sup>2</sup>), systolic blood pressure (129.05 ± 17.51 vs 123.43 ± 14.82 mmHg), and urinary creatinine [158.40 (74.75, 219.15) vs 79.70 (56.25, 138.10) μmmol/kg] levels was noted after 30-day Cana monotherapy (P < 0.05).…”
  15. 32095

    Genetic screen in haploid ESCs for PMP resistance identifies Anoikis modulators. by Giulio Di Minin (4768200)

    Published 2022
    “…Asterisks denote statistical significance for difference between indicated samples. …”
  16. 32096

    DataSheet_2_Canagliflozin alters the gut, oral, and ocular surface microbiota of patients with type 2 diabetes mellitus.xls by Limin Wang (87511)

    Published 2023
    “…</p>Clinical parameters<p>A significant decrease in fasting plasma glucose (8.22 ± 2.19 vs 6.87 ± 1.09 mmol/L), glycated serum protein [291.00 (264.00, 353.00) vs 275.00 (251.00, 342.50) μmol/L], hemoglobin A1c (7.39 ± 1.18 vs 7.12 ± 1.33%), body mass index (25.32 ± 2.99 vs 24.83 ± 2.95 kg/m<sup>2</sup>), systolic blood pressure (129.05 ± 17.51 vs 123.43 ± 14.82 mmHg), and urinary creatinine [158.40 (74.75, 219.15) vs 79.70 (56.25, 138.10) μmmol/kg] levels was noted after 30-day Cana monotherapy (P < 0.05).…”
  17. 32097

    Image 2_Deciphering the oncogenic network: how C1QTNF1-AS1 modulates osteosarcoma through miR-34a-5p and glycolytic pathways.tif by Yu Zhang (12946)

    Published 2025
    “…</p>Results<p>The findings indicated a significant decrease in C1QTNF1-AS1 expression levels in OS cells compared to normal osteoblasts. …”
  18. 32098

    GOFAs reflect differences in genetic backgrounds. by Nozomu Saeki (15374719)

    Published 2023
    “…<p><b>A)</b> Relationship between CaCl<sub>2</sub> addition and growth rates of various <i>S</i>. …”
  19. 32099

    Image 3_Deciphering the oncogenic network: how C1QTNF1-AS1 modulates osteosarcoma through miR-34a-5p and glycolytic pathways.tif by Yu Zhang (12946)

    Published 2025
    “…</p>Results<p>The findings indicated a significant decrease in C1QTNF1-AS1 expression levels in OS cells compared to normal osteoblasts. …”
  20. 32100

    Table 2_Deciphering the oncogenic network: how C1QTNF1-AS1 modulates osteosarcoma through miR-34a-5p and glycolytic pathways.docx by Yu Zhang (12946)

    Published 2025
    “…</p>Results<p>The findings indicated a significant decrease in C1QTNF1-AS1 expression levels in OS cells compared to normal osteoblasts. …”